22 November 2017
News and Views
Links and Services
A study in November's issue of the Alimentary Pharmacology & Therapeutics examines the association between aspirin use and the prevalence of nonalcoholic fatty liver disease.
Many basic mechanistic studies found that aspirin inhibited multiple pathways involved in non-alc
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors